- Patient assistance programs/manufacturer coupon programs
- Provide a complete financial analysis of potential plan savings from full & partial funding on specialty drugs including rebate loss & third-party fees
- Evaluate program requirements including changes to plan documents, financial qualification requirements of participating members, implementation timeline & member communication materials
- Provide detailed & unmatched reporting incorporating all funding claims data
- Stop-loss considerations
PBIRx specializes in specialty drug alternate funding
After years of vetting best-in-class solutions for specialty drug alternate funding, PBIRx developed a proprietary granular analysis based on member-specific claims data resulting in true accurate savings, versus inflated numbers.